Clinical trial
Chemoradiation in Locally Advanced Pancreatic Cancer
NCT00262951 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00262951 |
|---|---|
| Title | Chemoradiation in Locally Advanced Pancreatic Cancer |
| Official title | A Phase II Pilot Study of Multi-Agent Neo-Adjuvant Chemoradiation in Patients With Locally Advanced Pancreatic Adenocarcinoma |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | recombinant interferon alfa, cisplatin, fluorouracil, radiation therapy, Resection of tumor |
| Enrollment | 23 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Dec 7, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: